{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:17:41Z","timestamp":1783433861641,"version":"3.54.6"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11050-9","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:06:22Z","timestamp":1758549982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenic and clinical significance of inflammation-associated MicroRNAs in cardiovascular diseases"],"prefix":"10.1007","volume":"52","author":[{"given":"Arouj","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-1517","authenticated-orcid":false,"given":"Muhammad Jawad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"11050_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"A Cagnina","year":"1999","unstructured":"Cagnina A et al (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340:302\u2013309. https:\/\/doi.org\/10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"11050_CR2","unstructured":"Konstantinov IE, Mejevoi N, Anichkov NM (2006) Nikolai N. Anichkov and His Theory of Atherosclerosis. Tex Heart Inst J 33:417. Available: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1764970\/"},{"key":"11050_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/HC0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135\u20131143. https:\/\/doi.org\/10.1161\/HC0902.104353","journal-title":"Circulation"},{"key":"11050_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767\u20131772. https:\/\/doi.org\/10.1161\/01.CIR.101.15.1767","journal-title":"Circulation"},{"key":"11050_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s44161-024-00440-0","volume":"3","author":"S Sattler","year":"2024","unstructured":"Sattler S (2024) Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease. Nat Cardiovasc Res 3:245\u2013247. https:\/\/doi.org\/10.1038\/s44161-024-00440-0","journal-title":"Nat Cardiovasc Res"},{"key":"11050_CR6","doi-asserted-by":"publisher","DOI":"10.5334\/GH.1156","author":"A Matsumori","year":"2022","unstructured":"Matsumori A (2022) Targeting inflammation in the diagnosis, management, and prevention of cardiovascular diseases. Glob Heart. https:\/\/doi.org\/10.5334\/GH.1156","journal-title":"Glob Heart"},{"key":"11050_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4330\/WJC.V6.I6.462","volume":"6","author":"H Mangge","year":"2014","unstructured":"Mangge H, Becker K, Fuchs D, Gostner JM (2014) Antioxidants, inflammation and cardiovascular disease. World J Cardiol 6:462. https:\/\/doi.org\/10.4330\/WJC.V6.I6.462","journal-title":"World J Cardiol"},{"key":"11050_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"R PM","year":"2000","unstructured":"PM R, CH H, JE B, N R (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:1066\u20131067. https:\/\/doi.org\/10.1056\/NEJM200003233421202","journal-title":"N Engl J Med"},{"key":"11050_CR9","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1073\/PNAS.94.7.3195","volume":"94","author":"AG Wilson","year":"1997","unstructured":"Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195\u20133199. https:\/\/doi.org\/10.1073\/PNAS.94.7.3195","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11050_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0021-9150(01)00703-1","volume":"162","author":"RYL Zee","year":"2002","unstructured":"Zee RYL, Ridker PM (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:217\u2013219. https:\/\/doi.org\/10.1016\/S0021-9150(01)00703-1","journal-title":"Atherosclerosis"},{"key":"11050_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/HH1701.095642","volume":"89","author":"DH McDermott","year":"2001","unstructured":"McDermott DH et al (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:401\u2013407. https:\/\/doi.org\/10.1161\/HH1701.095642","journal-title":"Circ Res"},{"key":"11050_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.CJCA.2012.10.023","volume":"29","author":"ALH Webster","year":"2013","unstructured":"Webster ALH, Yan MSC, Marsden PA (2013) Epigenetics and cardiovascular disease. Can J Cardiol 29:46\u201357. https:\/\/doi.org\/10.1016\/J.CJCA.2012.10.023","journal-title":"Can J Cardiol"},{"key":"11050_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMOA072366\/SUPPL_FILE\/NEJMOA072366SA1.PDF","volume":"357","author":"NJ Samani","year":"2007","unstructured":"Samani NJ et al (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443\u2013453. https:\/\/doi.org\/10.1056\/NEJMOA072366\/SUPPL_FILE\/NEJMOA072366SA1.PDF","journal-title":"N Engl J Med"},{"key":"11050_CR14","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/FJ.14-260323","volume":"29","author":"JL Marques-Rocha","year":"2015","unstructured":"Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Mart\u00ednez JA, Marti A (2015) Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J 29:3595\u20133611. https:\/\/doi.org\/10.1096\/FJ.14-260323","journal-title":"FASEB J"},{"key":"11050_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.CELL.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan microRNAs. Cell 173:20\u201351. https:\/\/doi.org\/10.1016\/J.CELL.2018.03.006","journal-title":"Cell"},{"key":"11050_CR16","doi-asserted-by":"publisher","first-page":"7766","DOI":"10.3892\/MMR.2017.7575","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J et al (2017) Circulating miRNA 21 is a promising biomarker for heart failure. Mol Med Rep 16:7766\u20137774. https:\/\/doi.org\/10.3892\/MMR.2017.7575","journal-title":"Mol Med Rep"},{"key":"11050_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","volume":"100","author":"R Ji","year":"2007","unstructured":"Ji R et al (2007) Microrna expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100:1579\u20131588. https:\/\/doi.org\/10.1161\/CIRCRESAHA.106.141986","journal-title":"Circ Res"},{"key":"11050_CR18","doi-asserted-by":"publisher","first-page":"767064","DOI":"10.3389\/FCVM.2021.767064\/BIBTEX","volume":"8","author":"RA Surina","year":"2021","unstructured":"Surina RA, Fontanella R, Scisciola L, Marfella R, Paolisso G, Barbieri M (2021) miR-21 in human cardiomyopathies. Front Cardiovasc Med 8:767064. https:\/\/doi.org\/10.3389\/FCVM.2021.767064\/BIBTEX","journal-title":"Front Cardiovasc Med"},{"key":"11050_CR19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T et al (2008) Microrna-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980\u2013984. https:\/\/doi.org\/10.1038\/nature07511","journal-title":"Nature"},{"key":"11050_CR20","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.26355\/EURREV_201811_16420","volume":"22","author":"YQ Pan","year":"2018","unstructured":"Pan YQ, Li J, Li XW, Li YC, Li J, Lin JF (2018) Effect of miR-21\/TLR4\/NF-\u03baB pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion. Eur Rev Med Pharmacol Sci 22:7928\u20137937. https:\/\/doi.org\/10.26355\/EURREV_201811_16420","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11050_CR21","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.26355\/EURREV_202209_29632","volume":"26","author":"QY Yang","year":"2022","unstructured":"Yang QY et al (2022) Killing two birds with one stone: miR-126 involvement in both cancer and atherosclerosis. Eur Rev Med Pharmacol Sci 26:6145\u20136168. https:\/\/doi.org\/10.26355\/EURREV_202209_29632","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11050_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/NM.3487","volume":"20","author":"A Schober","year":"2014","unstructured":"Schober A et al (2014) Microrna-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 20:368\u2013376. https:\/\/doi.org\/10.1038\/NM.3487","journal-title":"Nat Med"},{"key":"11050_CR23","doi-asserted-by":"publisher","DOI":"10.18103\/MRA.V8I5.2133","volume":"8","author":"B Yu","year":"2020","unstructured":"Yu B, Jiang Y, Wang X, Wang S (2020) An integrated hypothesis for miR-126 in vascular disease. Med Res Arch 8:2133. https:\/\/doi.org\/10.18103\/MRA.V8I5.2133","journal-title":"Med Res Arch"},{"key":"11050_CR24","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/PNAS.0707493105","volume":"105","author":"TA Harris","year":"2008","unstructured":"Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ (2008) Microrna-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105:1516\u20131521. https:\/\/doi.org\/10.1073\/PNAS.0707493105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"11050_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/PHYSIOLGENOMICS.00133.2016","volume":"49","author":"MR Paterson","year":"2017","unstructured":"Paterson MR, Kriegel AJ (2017) MiR-146a\/b: a family with shared seeds and different roots. Physiol Genomics 49(4):243\u2013252. https:\/\/doi.org\/10.1152\/PHYSIOLGENOMICS.00133.2016","journal-title":"Physiol Genomics"},{"key":"11050_CR26","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/PNAS.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of MicroRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103:12481\u201312486. https:\/\/doi.org\/10.1073\/PNAS.0605298103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11050_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/J.NCRNA.2023.03.007","volume":"8","author":"I Khan","year":"2023","unstructured":"Khan I, Siraj M (2023) An updated review on cell signaling pathways regulated by candidate miRNAs in coronary artery disease. Noncoding RNA Res 8:326\u2013334. https:\/\/doi.org\/10.1016\/J.NCRNA.2023.03.007","journal-title":"Noncoding RNA Res"},{"key":"11050_CR28","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/S11033-022-07253-Z","volume":"49","author":"T Chu","year":"2022","unstructured":"Chu T, Xu X, Ruan Z, Wu L, Zhou M, Zhu G (2022) Mir-146a contributes to atherosclerotic plaque stability by regulating the expression of TRAF6 and IRAK-1. Mol Biol Rep 49:4205\u20134216. https:\/\/doi.org\/10.1007\/S11033-022-07253-Z","journal-title":"Mol Biol Rep"},{"key":"11050_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/MEDICINA57060575\/S1","volume":"57","author":"T Pereira-Da-Silva","year":"2021","unstructured":"Pereira-Da-Silva T et al (2021) Association between mir-146a and tumor necrosis factor alpha (Tnf-\u03b1) in stable coronary artery disease. Med (Lithuania) 57:575. https:\/\/doi.org\/10.3390\/MEDICINA57060575\/S1","journal-title":"Med (Lithuania)"},{"key":"11050_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/S12967-023-04140-4","volume":"21","author":"XR Qiao","year":"2023","unstructured":"Qiao XR et al (2023) MiR-146a rs2910164 (G\/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort. J Transl Med 21:325. https:\/\/doi.org\/10.1186\/S12967-023-04140-4","journal-title":"J Transl Med"},{"key":"11050_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/S12013-013-9704-7","volume":"68","author":"P Ramkaran","year":"2014","unstructured":"Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA (2014) Mir-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 68:259\u2013266. https:\/\/doi.org\/10.1007\/S12013-013-9704-7","journal-title":"Cell Biochem Biophys"},{"key":"11050_CR32","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1039\/D2NR03280E","volume":"15","author":"D Ho","year":"2023","unstructured":"Ho D et al (2023) MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation. Nanoscale 15:3461\u20133474. https:\/\/doi.org\/10.1039\/D2NR03280E","journal-title":"Nanoscale"},{"key":"11050_CR33","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/MMR.2020.11222","volume":"22","author":"B Han","year":"2020","unstructured":"Han B, Li T, Zheng S (2020) Microrna 133b aggravates atherosclerosis by activating the Notch signaling pathway. Mol Med Rep 22:1621\u20131630. https:\/\/doi.org\/10.3892\/MMR.2020.11222","journal-title":"Mol Med Rep"},{"key":"11050_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-222\/FIGURES\/5","volume":"11","author":"F Wang","year":"2013","unstructured":"Wang F et al (2013) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med 11:1\u20139. https:\/\/doi.org\/10.1186\/1479-5876-11-222\/FIGURES\/5","journal-title":"J Transl Med"},{"key":"11050_CR35","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/GR.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian MicroRNA host genes and transcription units. Genome Res 14:1902\u20131910. https:\/\/doi.org\/10.1101\/GR.2722704","journal-title":"Genome Res"},{"key":"11050_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25168605","volume":"25","author":"YE Torres- Paz","year":"2024","unstructured":"Torres-Paz YE et al (2024) Involvement of expression of miR33-5p and ABCA1 in human peripheral blood mononuclear cells in coronary artery disease. Int J Mol Sci 25:68605. https:\/\/doi.org\/10.3390\/IJMS25168605","journal-title":"Int J Mol Sci"},{"key":"11050_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4330\/WJC.V12.I7.303","volume":"12","author":"RJ Lightbody","year":"2020","unstructured":"Lightbody RJ, Walsh Taylor JM, Dempsie Y, Graham A (2020) MicroRNA sequences modulating inflammation and lipid accumulation in macrophage \u2018foam\u2019 cells: implications for atherosclerosis. World J Cardiol 12:303. https:\/\/doi.org\/10.4330\/WJC.V12.I7.303","journal-title":"World J Cardiol"},{"key":"11050_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS17101773","volume":"17","author":"H Zhou","year":"2016","unstructured":"Zhou H, Li J, Gao P, Wang Q, Zhang J (2016) MiR-155: a novel target in allergic asthma. Int J Mol Sci 17:1773. https:\/\/doi.org\/10.3390\/IJMS17101773","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11050_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1755-5922.12098","volume":"32","author":"W Xie","year":"2014","unstructured":"Xie W et al (2014) Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155\/SHIP-1 signaling pathway. Cardiovasc Ther 32(6):276\u2013282. https:\/\/doi.org\/10.1111\/1755-5922.12098","journal-title":"Cardiovasc Ther"},{"key":"11050_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0212-8","volume":"51","author":"M Park","year":"2019","unstructured":"Park M et al (2019) NF-\u03baB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase. Exp Mol Med 51:1\u201312. https:\/\/doi.org\/10.1038\/s12276-019-0212-8","journal-title":"Exp Mol Med"},{"key":"11050_CR41","doi-asserted-by":"publisher","unstructured":"Tang Y et al (2021) MiR-155 acts as an inhibitory factor in atherosclerosis-associated arterial pathogenesis by down-regulating NoxA1 related signaling pathway in ApoE\u2013\/\u2013 mouse. Cardiovasc Diagn Ther 13. https:\/\/doi.org\/10.21037\/CDT-20-518","DOI":"10.21037\/CDT-20-518"},{"key":"11050_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCRESAHA.115.304267\/-\/DC1","volume":"115","author":"J Streeter","year":"2014","unstructured":"Streeter J et al (2014) Phosphorylation of Nox1 regulates association with NoxA1 activation domain. Circ Res 115:911\u2013918. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.304267\/-\/DC1","journal-title":"Circ Res"},{"key":"11050_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/J.BBRC.2012.09.039","volume":"427","author":"S Matsumoto","year":"2012","unstructured":"Matsumoto S et al (2012) A subset of circulating MicroRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun 427:280\u2013284. https:\/\/doi.org\/10.1016\/J.BBRC.2012.09.039","journal-title":"Biochem Biophys Res Commun"},{"key":"11050_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4579806","volume":"2019","author":"J Guo","year":"2019","unstructured":"Guo J et al (2019) Microrna-155 promotes myocardial Infarction-induced apoptosis by targeting RNA-binding protein QKI. Oxid Med Cell Longev 2019:4579806. https:\/\/doi.org\/10.1155\/2019\/4579806","journal-title":"Oxid Med Cell Longev"},{"key":"11050_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/J.PRP.2024.155274","volume":"257","author":"R Eshraghi","year":"2024","unstructured":"Eshraghi R, Rafiei M, Hadian Jazi Z, Shafie D, Raisi A, Mirzaei H (2024) Microrna-155 and exosomal microrna-155: small pieces in the cardiovascular diseases puzzle. Pathol Res Pract 257:155274. https:\/\/doi.org\/10.1016\/J.PRP.2024.155274","journal-title":"Pathol Res Pract"},{"key":"11050_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3892\/ETM.2020.9259","volume":"20","author":"S Liang","year":"2020","unstructured":"Liang S, Hu J, Zhang A, Li F, Li X (2020) miR-155 induces endothelial cell apoptosis and inflammatory response in atherosclerosis by regulating Bmal1. Exp Ther Med 20:128. https:\/\/doi.org\/10.3892\/ETM.2020.9259","journal-title":"Exp Ther Med"},{"key":"11050_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6345284","volume":"2018","author":"Q Su","year":"2018","unstructured":"Su Q, Yang H, Li L (2018) Circulating miRNA-155 as a potential biomarker for coronary slow flow. Dis Markers 2018:6345284. https:\/\/doi.org\/10.1155\/2018\/6345284","journal-title":"Dis Markers"},{"key":"11050_CR48","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.3892\/ETM.2018.6797","volume":"16","author":"D Zhao","year":"2018","unstructured":"Zhao D et al (2018) The expression level of miR-155 in plasma and peripheral blood mononuclear cells in coronary artery disease patients and the associations of these levels with the apoptosis rate of peripheral blood mononuclear cells. Exp Ther Med 16:4373. https:\/\/doi.org\/10.3892\/ETM.2018.6797","journal-title":"Exp Ther Med"},{"key":"11050_CR49","doi-asserted-by":"publisher","first-page":"576516","DOI":"10.3389\/FIMMU.2020.576516","volume":"11","author":"S Fitzsimons","year":"2020","unstructured":"Fitzsimons S et al (2020) MicroRNA-155 is decreased during atherosclerosis regression and is increased in urinary extracellular vesicles during atherosclerosis progression. Front Immunol 11:576516. https:\/\/doi.org\/10.3389\/FIMMU.2020.576516","journal-title":"Front Immunol"},{"key":"11050_CR50","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.18632\/ONCOTARGET.3052","volume":"6","author":"B Humphries","year":"2015","unstructured":"Humphries B, Yang C (2015) The microrna-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget 6:6472. https:\/\/doi.org\/10.18632\/ONCOTARGET.3052","journal-title":"Oncotarget"},{"key":"11050_CR51","doi-asserted-by":"publisher","first-page":"693257","DOI":"10.3389\/FCVM.2021.693257\/BIBTEX","volume":"8","author":"ZQ Chen","year":"2021","unstructured":"Chen ZQ et al (2021) miR-200a-3p attenuates coronary Microembolization-Induced myocardial injury in rats by inhibiting TXNIP\/NLRP3-Mediated cardiomyocyte pyroptosis. Front Cardiovasc Med 8:693257. https:\/\/doi.org\/10.3389\/FCVM.2021.693257\/BIBTEX","journal-title":"Front Cardiovasc Med"},{"key":"11050_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2018.00355","volume":"9","author":"WY Lo","year":"2018","unstructured":"Lo WY, Yang WK, Peng CT, Pai WY, Wang HJ (2018) Microrna-200a\/200b modulate high glucose-induced endothelial inflammation by targeting O-linked n-acetylglucosamine transferase expression. Front Physiol 9:354921. https:\/\/doi.org\/10.3389\/FPHYS.2018.00355","journal-title":"Front Physiol"},{"key":"11050_CR53","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1042\/CS20180684","volume":"132","author":"A Magenta","year":"2018","unstructured":"Magenta A et al (2018) Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker. Clin Sci 132:2423\u20132436. https:\/\/doi.org\/10.1042\/CS20180684","journal-title":"Clin Sci"},{"key":"11050_CR54","doi-asserted-by":"publisher","DOI":"10.1152\/AJPRENAL.00269.2003","author":"B Rodr\u00edguez-Iturbe","year":"2004","unstructured":"Rodr\u00edguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. American Journal of Physiology-Renal Physiology. https:\/\/doi.org\/10.1152\/AJPRENAL.00269.2003","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"11050_CR55","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","volume":"128","author":"MS Madhur","year":"2021","unstructured":"Madhur MS et al (2021) Hypertension: do inflammation and immunity hold the key to solving this epidemic? Circ Res 128:908\u2013933. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318052","journal-title":"Circ Res"},{"key":"11050_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/MNH.0000000000000680","volume":"30","author":"DP Basile","year":"2021","unstructured":"Basile DP, Abais-Battad JM, Mattson DL (2021) Contribution of Th17 cells to tissue injury in hypertension. Curr Opin Nephrol Hypertens 30:151\u2013158. https:\/\/doi.org\/10.1097\/MNH.0000000000000680","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"11050_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/HYPERTENSIONAHA.114.04147\/-\/DC1","volume":"64","author":"DW Trott","year":"2014","unstructured":"Trott DW et al (2014) Oligoclonal CD8\u2009+\u2009T cells play a critical role in the development of hypertension. Hypertension 64:1108\u20131115. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04147\/-\/DC1","journal-title":"Hypertension"},{"key":"11050_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/JCP.30969","volume":"238","author":"A Bell-Hensley","year":"2023","unstructured":"Bell-Hensley A, Das S, McAlinden A (2023) The miR-181 family: wide-ranging pathophysiological effects on cell fate and function. J Cell Physiol 238:698. https:\/\/doi.org\/10.1002\/JCP.30969","journal-title":"J Cell Physiol"},{"key":"11050_CR59","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1172\/JCI61495","volume":"122","author":"X Sun","year":"2012","unstructured":"Sun X et al (2012) MicroRNA-181b regulates NF-\u03baB-mediated vascular inflammation. J Clin Invest 122:1973\u20131990. https:\/\/doi.org\/10.1172\/JCI61495","journal-title":"J Clin Invest"},{"key":"11050_CR60","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/ONC.2014.274","volume":"34","author":"R Su","year":"2015","unstructured":"Su R et al (2015) Mir-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene 34:3226\u20133239. https:\/\/doi.org\/10.1038\/ONC.2014.274","journal-title":"Oncogene"},{"key":"11050_CR61","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/CDD.2011.127","volume":"19","author":"X Li","year":"2012","unstructured":"Li X et al (2012) MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ 19:378\u2013386. https:\/\/doi.org\/10.1038\/CDD.2011.127","journal-title":"Cell Death Differ"},{"key":"11050_CR62","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/J.IMMUNI.2013.02.021","volume":"38","author":"J Henao-Mejia","year":"2013","unstructured":"Henao-Mejia J et al (2013) The microrna miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38:984\u2013997. https:\/\/doi.org\/10.1016\/J.IMMUNI.2013.02.021","journal-title":"Immunity"},{"key":"11050_CR63","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.4049\/JIMMUNOL.1100835","volume":"187","author":"F Cichocki","year":"2011","unstructured":"Cichocki F et al (2011) Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol 187:6171\u20136175. https:\/\/doi.org\/10.4049\/JIMMUNOL.1100835","journal-title":"J Immunol"},{"key":"11050_CR64","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/HYPERTENSIONAHA.113.01701\/-\/DC1","volume":"62","author":"KL Jackson","year":"2013","unstructured":"Jackson KL et al (2013) A novel interaction between sympathetic overactivity and aberrant regulation of Renin by miR-181a in BPH\/2J genetically hypertensive mice. Hypertension 62:775\u2013781. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01701\/-\/DC1","journal-title":"Hypertension"},{"key":"11050_CR65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2119\/MOLMED.2015.00096","volume":"21","author":"FZ Marques","year":"2015","unstructured":"Marques FZ et al (2015) Signatures of miR-181a on the renal transcriptome and blood pressure. Mol Med 21:739. https:\/\/doi.org\/10.2119\/MOLMED.2015.00096","journal-title":"Mol Med"},{"key":"11050_CR66","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1002\/JCP.29318","volume":"235","author":"H Zhao","year":"2020","unstructured":"Zhao H, Guo Y, Sun Y, Zhang N, Wang X (2020) Mir-181a\/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan. J Cell Physiol 235:4422\u20134433. https:\/\/doi.org\/10.1002\/JCP.29318","journal-title":"J Cell Physiol"},{"key":"11050_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/J.BBADIS.2009.02.013","volume":"1792","author":"I Faraoni","year":"2009","unstructured":"Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009) MiR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792:497\u2013505. https:\/\/doi.org\/10.1016\/J.BBADIS.2009.02.013","journal-title":"Biochim Biophys Acta"},{"key":"11050_CR68","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/PNAS.0610731104","volume":"104","author":"RM O\u2019Connell","year":"2007","unstructured":"O\u2019Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) Microrna-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104:1604\u20131609. https:\/\/doi.org\/10.1073\/PNAS.0610731104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11050_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/J.LFS.2018.10.028","volume":"213","author":"H Zhang","year":"2018","unstructured":"Zhang H et al (2018) Endothelial dysfunction in diabetes and hypertension: role of MicroRNAs and long non-coding RNAs. Life Sci 213:258\u2013268. https:\/\/doi.org\/10.1016\/J.LFS.2018.10.028","journal-title":"Life Sci"},{"key":"11050_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2019.00893","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J, Cao Z, Yang G, You L, Zhang T, Zhao Y (2019) MicroRNA-27a (miR-27a) in solid tumors: a review based on mechanisms and clinical observations. Front Oncol 9:893. https:\/\/doi.org\/10.3389\/FONC.2019.00893","journal-title":"Front Oncol"},{"key":"11050_CR71","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4049\/JIMMUNOL.1400203","volume":"193","author":"N Xie","year":"2014","unstructured":"Xie N et al (2014) MiR-27a regulates inflammatory response of macrophages by targeting IL-10. J Immunol 193:327. https:\/\/doi.org\/10.4049\/JIMMUNOL.1400203","journal-title":"J Immunol"},{"key":"11050_CR72","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/BLOOD-2011-08-373886","volume":"119","author":"C Urbich","year":"2012","unstructured":"Urbich C et al (2012) MicroRNA-27a\/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119:1607\u20131618. https:\/\/doi.org\/10.1182\/BLOOD-2011-08-373886","journal-title":"Blood"},{"key":"11050_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/J.LFS.2019.04.038","volume":"227","author":"T Liu","year":"2019","unstructured":"Liu T et al (2019) Mir-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling. Life Sci 227:64\u201373. https:\/\/doi.org\/10.1016\/J.LFS.2019.04.038","journal-title":"Life Sci"},{"key":"11050_CR74","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/J.BBRC.2015.03.057","volume":"460","author":"R Bi","year":"2015","unstructured":"Bi R et al (2015) Microrna-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor \u03b3 dependent Hsp90-eNOS signaling and nitric oxide production. Biochem Biophys Res Commun 460:469\u2013475. https:\/\/doi.org\/10.1016\/J.BBRC.2015.03.057","journal-title":"Biochem Biophys Res Commun"},{"key":"11050_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/AJH\/HPZ112","volume":"33","author":"X Zou","year":"2020","unstructured":"Zou X et al (2020) Secreted monocyte miR-27a, via mesenteric arterial Mas receptor-eNOS pathway, causes hypertension. Am J Hypertens 33:31\u201342. https:\/\/doi.org\/10.1093\/AJH\/HPZ112","journal-title":"Am J Hypertens"},{"key":"11050_CR76","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/J.BBRC.2019.01.047","volume":"509","author":"MM Xu","year":"2019","unstructured":"Xu MM, Deng HY, Li HH (2019) Microrna-27a regulates angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting \u03b1-smooth muscle-actin in vitro. Biochem Biophys Res Commun 509:973\u2013977. https:\/\/doi.org\/10.1016\/J.BBRC.2019.01.047","journal-title":"Biochem Biophys Res Commun"},{"key":"11050_CR77","doi-asserted-by":"publisher","first-page":"41058","DOI":"10.1038\/SREP41058","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) Secreted miR-27a induced by cyclic stretch modulates the proliferation of endothelial cells in hypertension via GRK6. Sci Rep 7:41058. https:\/\/doi.org\/10.1038\/SREP41058","journal-title":"Sci Rep"},{"key":"11050_CR78","doi-asserted-by":"publisher","first-page":"8720661","DOI":"10.1155\/2022\/8720661","volume":"2022","author":"Y Masoumi-Ardakani","year":"2022","unstructured":"Masoumi-Ardakani Y, Najafipour H, Nasri HR, Aminizadeh S, Jafari SJ, Moflehi D (2022) Effect of combined endurance training and MitoQ on cardiac function and serum level of Antioxidants, NO, miR-126, and miR-27a in hypertensive individuals. Biomed Res Int 2022:8720661. https:\/\/doi.org\/10.1155\/2022\/8720661","journal-title":"Biomed Res Int"},{"key":"11050_CR79","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/S00246-021-02592-3","volume":"42","author":"H Zhao","year":"2021","unstructured":"Zhao H et al (2021) The influence of Bosentan on MicroRNA-27a\/PPAR\u03b3\/ET-1 signaling pathway in pulmonary artery hypertension. Pediatr Cardiol 42:1141\u20131148. https:\/\/doi.org\/10.1007\/S00246-021-02592-3","journal-title":"Pediatr Cardiol"},{"key":"11050_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000811","author":"J Alam","year":"2024","unstructured":"Alam J, Rahman SZ, Alam S, Hasan A, Haseen MA, Sarfraz M (2024) The involvement of miR-221\/222 in vascular pathophysiology: implications for stenting. Cardiol Rev. https:\/\/doi.org\/10.1097\/CRD.0000000000000811","journal-title":"Cardiol Rev"},{"key":"11050_CR81","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.108.185363","volume":"104","author":"X Liu","year":"2009","unstructured":"Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104:476. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.185363","journal-title":"Circ Res"},{"key":"11050_CR82","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.117.10094\/SUPPL_FILE\/HYP_HYPE201710094D_SUPP1.PDF","volume":"71","author":"R Verjans","year":"2018","unstructured":"Verjans R, van Leeuwen REW, Heggermont W et al (2018) MicroRNA-221\/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure. Hypertension 71:280\u2013288. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10094\/SUPPL_FILE\/HYP_HYPE201710094D_SUPP1.PDF","journal-title":"Hypertension"},{"key":"11050_CR83","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/BIOMEDICINES9080860","volume":"9","author":"G Mandraffino","year":"2021","unstructured":"Mandraffino G, Riggio S, Zoccali C et al (2021) Expression and change of MiRs 145, 221 and 222 in hypertensive subjects treated with enalapril, Losartan or Olmesartan. Biomedicines 9:860. https:\/\/doi.org\/10.3390\/BIOMEDICINES9080860","journal-title":"Biomedicines"},{"key":"11050_CR84","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.26355\/EURREV_201811_16283","volume":"22","author":"D Xu","year":"2018","unstructured":"Xu D, Liao R, Wang XX, Cheng Z (2018) Effects of miR-155 on hypertensive rats via regulating vascular mesangial hyperplasia. Eur Rev Med Pharmacol Sci 22:7431\u20137438. https:\/\/doi.org\/10.26355\/EURREV_201811_16283","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11050_CR85","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41371-019-0250-7","volume":"34","author":"YQ Huang","year":"2019","unstructured":"Huang YQ, Huang C, Zhang B, Feng YQ (2019) Association of circulating miR-155 expression level and inflammatory markers with white coat hypertension. J Hum Hypertens 34:397\u2013403. https:\/\/doi.org\/10.1038\/s41371-019-0250-7","journal-title":"J Hum Hypertens"},{"key":"11050_CR86","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/S13273-020-00083-9","volume":"16","author":"SD Chai","year":"2020","unstructured":"Chai SD, Li Y, Zhang L et al (2020) The role of miRNA-155 in monocrotaline-induced pulmonary arterial hypertension through c-Fos\/NLRP3\/caspase-1. Mol Cell Toxicol 16:311\u2013320. https:\/\/doi.org\/10.1007\/S13273-020-00083-9","journal-title":"Mol Cell Toxicol"},{"key":"11050_CR87","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.26355\/EURREV_201810_16133","volume":"22","author":"DF Liu","year":"2018","unstructured":"Liu DF, Li SM, Zhu QX, Jiang W (2018) The involvement of miR-155 in blood pressure regulation in pregnant hypertension rat via targeting FOXO3a. Eur Rev Med Pharmacol Sci 22:6591\u20136598. https:\/\/doi.org\/10.26355\/EURREV_201810_16133","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11050_CR88","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/CIRCULATIONAHA.109.918417","volume":"122","author":"G Brevetti","year":"2010","unstructured":"Brevetti G, Giugliano G, Brevetti L, Hiatt WR (2010) Inflammation in peripheral artery disease. Circulation 122:1862\u20131875. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.918417","journal-title":"Circulation"},{"key":"11050_CR89","doi-asserted-by":"publisher","first-page":"8504238","DOI":"10.1155\/2020\/8504238","volume":"2020","author":"M Wang","year":"2020","unstructured":"Wang M, Zhang Y, Li X et al (2020) Overexpression of microRNA-16 alleviates atherosclerosis by Inhibition of inflammatory pathways. Biomed Res Int 2020:8504238. https:\/\/doi.org\/10.1155\/2020\/8504238","journal-title":"Biomed Res Int"},{"key":"11050_CR90","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3892\/IJMM.2016.2497","volume":"37","author":"X Liang","year":"2016","unstructured":"Liang X, Tang J, Gao Y et al (2016) MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4. Int J Mol Med 37:967\u2013975. https:\/\/doi.org\/10.3892\/IJMM.2016.2497","journal-title":"Int J Mol Med"},{"key":"11050_CR91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.111.300418","volume":"112","author":"G Spinetti","year":"2013","unstructured":"Spinetti G, Fortunato O, Caporali A et al (2013) Microrna-15a and microrna-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res 112:335\u2013346. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.300418","journal-title":"Circ Res"},{"key":"11050_CR92","doi-asserted-by":"publisher","DOI":"10.1161\/CIRC.126.SUPPL_21.A19506","author":"S Sorrentino","year":"2012","unstructured":"Sorrentino S et al (2012) The role of miR-16 on endothelial dysfunction in rat with atherosclerotic diet with a chronic model of femoral artery occlusion and carotid balloon injury. Circulation. https:\/\/doi.org\/10.1161\/CIRC.126.SUPPL_21.A19506. 126:suppl_21","journal-title":"Circulation"},{"key":"11050_CR93","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bbrc.2020.05.104","volume":"528","author":"L Liu","year":"2020","unstructured":"Liu L (2020) The anti-inflammatory effect of miR-16 through targeting C-reactive protein is regulated by HuR in vascular smooth muscle cells. Biochem Biophys Res Commun 528:636\u2013643. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.104","journal-title":"Biochem Biophys Res Commun"},{"key":"11050_CR94","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.3892\/ETM.2019.7552","volume":"18","author":"Y Sun","year":"2019","unstructured":"Sun Y, Gao Y, Song T, Yu C, Nie Z, Wang X (2019) MicroRNA-15b participates in the development of peripheral arterial disease by modulating the growth of vascular smooth muscle cells. Exp Ther Med 18:7552. https:\/\/doi.org\/10.3892\/ETM.2019.7552","journal-title":"Exp Ther Med"},{"key":"11050_CR95","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/ATVBAHA.116.308905","volume":"37","author":"LP Zhu","year":"2017","unstructured":"Zhu LP, Li Y et al (2017) MiR-15b-5p regulates collateral artery formation by targeting AKT3 (Protein kinase B-3). Arterioscler Thromb Vasc Biol 37:957\u2013968. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308905","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11050_CR96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.JVSSCI.2020.02.001","volume":"1","author":"TA Sorrentino","year":"2020","unstructured":"Sorrentino TA et al (2020) Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microrna cargo. JVS-Vascular Science 1:28\u201341. https:\/\/doi.org\/10.1016\/J.JVSSCI.2020.02.001","journal-title":"JVS-Vascular Science"},{"key":"11050_CR97","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/JCB.26567","volume":"120","author":"SX Ma","year":"2019","unstructured":"Ma SX, Bai ZF, Wang W, Wu HY (2019) Effects of microRNA-93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF-\u03baB pathway. J Cell Biochem 120:2847\u20132858. https:\/\/doi.org\/10.1002\/JCB.26567","journal-title":"J Cell Biochem"},{"key":"11050_CR98","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.116.025490","volume":"135","author":"VC Ganta","year":"2017","unstructured":"Ganta VC, Choi MH, Kutateladze A, Fox TE, Farber CR, Annex BH (2017) A microrna93-IRF9-IRG1-itaconic acid pathway modulates M2-like macrophage polarization to revascularize ischemic muscle. Circulation 135:2403. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025490","journal-title":"Circulation"},{"key":"11050_CR99","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3892\/ETM.2018.7000","volume":"17","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wang Q, Rao G, Qiu J, He R (2018) Curcumin improves perfusion recovery in experimental peripheral arterial disease by upregulating microRNA-93 expression. Exp Ther Med 17:798. https:\/\/doi.org\/10.3892\/ETM.2018.7000","journal-title":"Exp Ther Med"},{"key":"11050_CR100","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.3390\/MOLECULES27207110\/S1","volume":"27","author":"G Froldi","year":"2022","unstructured":"Froldi G, Ragazzi E (2022) Selected plant-derived polyphenols as potential therapeutic agents for peripheral artery disease: molecular mechanisms, efficacy and safety. Molecules 27:7110. https:\/\/doi.org\/10.3390\/MOLECULES27207110\/S1","journal-title":"Molecules"},{"key":"11050_CR101","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.3892\/MMR.2019.10196","volume":"19","author":"X Shu","year":"2019","unstructured":"Shu X et al (2019) MicroRNA-93 regulates angiogenesis in peripheral arterial disease by targeting CDKN1A. Mol Med Rep 19:5195. https:\/\/doi.org\/10.3892\/MMR.2019.10196","journal-title":"Mol Med Rep"},{"key":"11050_CR102","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033674","volume":"13","author":"H Karlin","year":"2024","unstructured":"Karlin H et al (2024) Plasma extracellular microRNAs associated with cardiovascular disease risk factors in middle-aged and older adults. J Am Heart Assoc 13:33674. https:\/\/doi.org\/10.1161\/JAHA.123.033674","journal-title":"J Am Heart Assoc"},{"key":"11050_CR103","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.gendis.2022.05.022","volume":"10","author":"A Dandare","year":"2023","unstructured":"Dandare A, Khan MJ, Naeem A, Liaquat A (2023) Clinical relevance of circulating non-coding RNAs in metabolic diseases: emphasis on obesity, diabetes, cardiovascular disease and metabolic syndrome. Genes Dis 10:2393\u20132413. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.022","journal-title":"Genes Dis"},{"key":"11050_CR104","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/GENES14030550","volume":"14","author":"M Rafiq","year":"2023","unstructured":"Rafiq M et al (2023) Competing endogenous RNA regulatory networks of hsa_circ_0126672 in pathophysiology of coronary heart disease. Genes (Basel) 14:550. https:\/\/doi.org\/10.3390\/GENES14030550","journal-title":"Genes (Basel)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11050-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:46Z","timestamp":1766898226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11050-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11050"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11050-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"940"}}